![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humans
|
|
|
AIDS 2022 July 29-Aug 2 Montreal
Randolph P. Matthews,1 Kerry L. Fillgrove,1 Munjal Patel,1 Wen Liu,1 Catherine Z. Matthews,1 Yang Liu,1 Irene Mirkin,2 S. Aubrey Stoch,1 Marian Iwamoto1
1Merck & Co., Inc., Rahway, NJ, USA; 2Labcorp Clinical Research Unit, Madison, WI, USA
![0807221copy](../images/080821/080822-2/0807221copy.gif)
![0807222copy](../images/080821/080822-2/0807222copy.gif)
![0807223copy](../images/080821/080822-2/0807223copy.gif)
![0807224copy](../images/080821/080822-2/0807224copy.gif)
![0807225copy](../images/080821/080822-2/0807225copy.gif)
![0807226copy](../images/080821/080822-2/0807226copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|